FDAnews
www.fdanews.com/articles/108162-glaxosmithkline-cervarix-won-rsquo-t-need-additional-tests

GlaxoSmithKline: Cervarix Won’t Need Additional Tests

June 30, 2008

GSK said it doesn’t expect the U.S. Food and Drug Administration to require additional studies for its vaccine to prevent cervical cancer before it can gain approval. Responding to questions raised by the FDA, the drug company said studies to be completed later this year for its Cervarix vaccine are likely to be enough to strengthen its case.
MarketWatch